There is an urgent need to increase the number of clinicians able to treat hepatitis B and hepatitis C. Until 1 March 2016, therapy uptake for HCV was slow, due to both hard to reach priority populations and the difficulty and length of the treatment itself. In hepatitis B, many people remain undiagnosed and confusion still exists around the idea of a ‘healthy carrier’, masking the need for monitoring and, in some cases, the prescription of effective therapy.
This is the first time that the Australasian Viral Hepatitis Elimination Conference (AVHEC) will be held. It is to be held in the off-year of the Australasian Viral Hepatitis Conference to cater for the educational needs of clinicians and researchers given the major changes that are happening in the sector. The conference is taking place 10-11 August, Pullman International, Cairns, Queensland.
For more information view the conference website www.avhec.com.au or contact the Conference Secretariat
P: 02 8204 0770